-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Clover Health Investments, Maintains $3.7 Price Target

Benzinga·01/20/2026 15:40:13
Listen to the news
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and maintains $3.7 price target.